FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Labetalol Hydrochloride Tablet
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc. (New 03/11/2024)

Company Contact Information:
800-545-8800

Presentation	Posting Date	Related Information
Tablet, 100 mg (NDC 0591-0605-01)	03/11/2024	Permanent discontinuation in the manufacturing of the drug
Tablet, 100 mg (NDC 0591-0605-05)	03/11/2024	Permanent discontinuation in the manufacturing of the drug
Tablet, 200 mg (NDC 0591-0606-01)	03/11/2024	Permanent discontinuation in the manufacturing of the drug
Tablet, 200 mg (NDC 0591-0606-05)	03/11/2024	Permanent discontinuation in the manufacturing of the drug
Tablet, 300 mg (NDC 0591-0607-01)	03/11/2024	Permanent discontinuation in the manufacturing of the drug